JOSEPH B. KIRSNER, M.D., Ph.D., F.A.C.P.; WALTER L. PALMER, M.D., Ph.D., F.A.C.P.
This content is PDF only. Please click on the PDF icon to access.
The effects of corticotropin (ACTH) and cortisone in ulcerative colitis have been characterized as beneficial,1-5 indifferent6-8 and unfavorable.9-14 Numerous studies also have emphasized the complications of therapy and the recurrences.15-20 The observation of 40 patients in 19511 indicated that, while ACTH and cortisone do not cure ulcerative colitis, they may be useful adjuncts, initiating rapid and occasionally dramatic clinical improvement. The present report summarizes our experience with corticotropin and cortisone in 120 patients with ulcerative colitis observed during the past four years.
General Data: The series includes 65 females and 55 males; the majority were between 20
KIRSNER JB, PALMER WL. ULCERATIVE COLITIS: THERAPEUTIC EFFECTS OF CORTICOTROPIN (ACTH) AND CORTISONE IN 120 PATIENTS*†. Ann Intern Med. 1954;41:232–250. doi: https://doi.org/10.7326/0003-4819-41-2-232
Download citation file:
Published: Ann Intern Med. 1954;41(2):232-250.
Gastroenterology/Hepatology, Inflammatory Bowel Disease.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use